Details for Patent: 12,005,069

Which drugs does patent 12,005,069 protect, and when does it expire?

Patent 12,005,069 protects BORTEZOMIB and is included in one NDA.

This patent has one patent family member in one country.

Summary for Patent: 12,005,069

Title:	Bortezomib compositions
Abstract:	The present disclosure relates to ready-to-use liquid aqueous bortezomib compositions bortezomib and pharmaceutical excipients. Other aspects include methods of preparing such ready-to-use liquid aqueous bortezomib compositions, and methods of using such ready-to-use liquid bortezomib compositions in therapeutic applications.
Inventor(s):	Srikanth Sundaram, Daniel Charles Stewart
Assignee:	Maia Pharmaceuticals Inc
Application Number:	US18/456,759
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 12,005,069
Patent Claim Types: see list of patent claims	Composition; Compound;

Drugs Protected by US Patent 12,005,069

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Maia Pharms Inc	BORTEZOMIB	bortezomib	SOLUTION;INTRAVENOUS	215331-001	Jul 27, 2022		DISCN	Yes	No	12,005,069		Y
Maia Pharms Inc	BORTEZOMIB	bortezomib	SOLUTION;INTRAVENOUS	215331-002	Jul 27, 2022		DISCN	Yes	No	12,005,069		Y

International Family Members for US Patent 12,005,069

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
World Intellectual Property Organization (WIPO)	2023049346